A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis

NCT03630939 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Plaque

Interventions

DRUG: ESR-114
OTHER: Placebo

Sponsor

Escalier Biosciences B.V.

Collaborators

[object Object]